Cross-Sector entity
Of the tracked stories, 3 of 3 also mention Accu-Fab, the most common co-covered peer. Coverage clusters in construction-tech, which accounts for 1 of those 3, with the remainder spread across 2 other categories. We currently track 3 Cross-Sector stories that mention Miami International, all published on August 8, 2026.
3 verified stories tracked
Last mentioned: Aug 8, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Of the tracked stories, 3 of 3 also mention Accu-Fab, the most common co-covered peer. Coverage clusters in construction-tech, which accounts for 1 of those 3, with the remainder spread across 2 other categories. We currently track 3 Cross-Sector stories that mention Miami International, all published on August 8, 2026. Each carries 3 original sources on average.
Computed from the 3 stories linked to this entity. Beat comparisons are omitted because no baseline was available for this window.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Miami International. Shared-story counts are live from our verified record — not editorial picks.
Mayville Engineering’s Q2 results reveal a staggering 173% organic growth in data center and critical power revenue, underscoring the property-tech sector's long-term structural tailwind from artificial intelligence. With a pipeline exceeding $125 million, MEC is a bellwether for the construction boom in digital infrastructure.
Biofuel producer Alto Ingredients posted its fourth straight profitable quarter as crush margins expanded to $0.33 per gallon from $0.11 a year ago and 45Z tax credits kicked in. The results demonstrate how federal low-carbon fuel policy is strengthening the ethanol business case.
Urogen Pharma’s bladder cancer therapy ZUSDURI generated $50.4M in Q2 net product revenue, a 73% sequential jump, as the company activated 1,444 accounts and doubled repeat prescribers. The strong commercial launch highlights robust demand in biotech’s niche oncology space.
Source: themarketsdaily.com · dailypolitical.com
